The NF‐κB pathway is considered a key regulatory pathway for modulating Th2 inflammation in allergic diseases such as asthma, involved in the activation of various inflammatory cells and the production of inflammatory mediators, such as IL‐4, IL‐5, and IL‐13.49 This evidence concerns the gene IL13 and allergic disease.